• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病1型调控元件作为组织型纤溶酶原激活剂表达的抑制剂发挥作用。

NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.

作者信息

Pham Nhat-Long, Franzen Amy, Levin Eugene G

机构信息

Division of Vascular Biology, La Jolla Institute for Molecular Medicine, San Diego Calif 92121, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2004 May;24(5):982-7. doi: 10.1161/01.ATV.0000126679.70877.d0. Epub 2004 Mar 25.

DOI:10.1161/01.ATV.0000126679.70877.d0
PMID:15044208
Abstract

OBJECTIVE

Analysis of the distribution of endothelial cell tissue plasminogen activator (tPA) in the vasculature of rodents and primates demonstrated that tPA is constitutively expressed predominantly in small artery endothelial cells of brain and lung. The regulatory elements responsible for the highly selective expression of arterial endothelial cell tissue plasminogen activator were sought.

METHODS AND RESULTS

Transcription factor binding sites were defined by electrophoretic mobility-shift assay (EMSA) analysis using rat lung and brain nuclear extracts and the tPA promoter sequence from -609 to +37 bp. Protein binding to the promoter was found to be mediated by an NF1 site between -158 and -145 bp upstream from the transcriptional start site. Specific binding was confirmed through mutational analysis and competition binding studies. Infection of endothelial cells with a tPA promoter-green fluorescent protein (GFP) (-609 to +37 bp) reporter construct resulted in expression of the GFP, whereas no expression was found in smooth muscle cells. Mutation of the NF1 site increased the GFP expression indicating that the element acts as a repressor.

CONCLUSIONS

These results suggest that the 600 bp of the tPA promoter upstream of the transcription start site conveys cell specificity to tPA expression and that an NF1 site within this region acts as a repressor.

摘要

目的

对啮齿动物和灵长类动物脉管系统中内皮细胞组织型纤溶酶原激活物(tPA)分布的分析表明,tPA主要在脑和肺的小动脉内皮细胞中组成性表达。研究了负责动脉内皮细胞组织型纤溶酶原激活物高度选择性表达的调控元件。

方法与结果

利用大鼠肺和脑的核提取物以及从-609至+37 bp的tPA启动子序列,通过电泳迁移率变动分析(EMSA)确定转录因子结合位点。发现与启动子的蛋白结合是由转录起始位点上游-158至-145 bp之间的一个NF1位点介导的。通过突变分析和竞争结合研究证实了特异性结合。用tPA启动子-绿色荧光蛋白(GFP)(-609至+37 bp)报告基因构建体感染内皮细胞导致GFP表达,而在平滑肌细胞中未发现表达。NF1位点的突变增加了GFP表达,表明该元件起阻遏作用。

结论

这些结果表明,转录起始位点上游600 bp的tPA启动子赋予tPA表达细胞特异性,并且该区域内的一个NF1位点起阻遏作用。

相似文献

1
NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.神经纤维瘤病1型调控元件作为组织型纤溶酶原激活剂表达的抑制剂发挥作用。
Arterioscler Thromb Vasc Biol. 2004 May;24(5):982-7. doi: 10.1161/01.ATV.0000126679.70877.d0. Epub 2004 Mar 25.
2
Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.核因子Y(NFY)和E2F1对小鼠PNRC2启动子的转录调控。
Gene. 2005 Nov 21;361:89-100. doi: 10.1016/j.gene.2005.07.012. Epub 2005 Sep 21.
3
E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.在人前列腺癌细胞系PC-3-M中,Op18启动子中的E2F位点是高水平表达所必需的。
Gene. 2004 Oct 27;341:209-18. doi: 10.1016/j.gene.2004.06.052.
4
Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.人类SOX3启动子的功能特性:参与基础启动子活性的转录因子的鉴定
Gene. 2005 Jan 3;344:287-97. doi: 10.1016/j.gene.2004.11.006. Epub 2004 Dec 10.
5
Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.Ets转录因子结合并反式激活血管性血友病因子基因的核心启动子。
Oncogene. 1997 Dec 18;15(25):3091-102. doi: 10.1038/sj.onc.1201502.
6
Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.ZFP106的双启动子结构:受肌细胞生成素和核呼吸因子-1调控。
Gene. 2005 Jan 3;344:143-59. doi: 10.1016/j.gene.2004.09.035. Epub 2004 Nov 19.
7
Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity.肌肉可塑性的转录调控:电活动对肌钙蛋白I基因的差异调控。
Dev Genet. 1996;19(2):169-81. doi: 10.1002/(SICI)1520-6408(1996)19:2<169::AID-DVG9>3.0.CO;2-7.
8
Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.USF-1与大鼠1型纤溶酶原激活物抑制剂基因近端启动子E盒元件的生长状态依赖性结合。
Exp Cell Res. 2000 Oct 10;260(1):127-35. doi: 10.1006/excr.2000.5001.
9
Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.β-淀粉样前体蛋白基因在不同细胞系中的启动子活性机制:近端启动子区域中一个特定30bp片段的鉴定
J Neurochem. 2004 Sep;90(6):1432-44. doi: 10.1111/j.1471-4159.2004.02608.x.
10
Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.新型癌症相关基因1A6/DRIM启动子的特征分析及其转录激活因子的鉴定
Gene. 2005 Jan 3;344:161-9. doi: 10.1016/j.gene.2004.09.036. Epub 2004 Nov 19.

引用本文的文献

1
Differential Promoter Methylation in Bipolar Disorder With or Without Addiction.伴有或不伴有成瘾的双相情感障碍中的启动子甲基化差异
Front Cell Neurosci. 2017 Jul 21;11:217. doi: 10.3389/fncel.2017.00217. eCollection 2017.
2
Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.调控元件DNA甲基化对组织型纤溶酶原激活剂基因表达的影响。
PLoS One. 2016 Dec 14;11(12):e0167588. doi: 10.1371/journal.pone.0167588. eCollection 2016.
3
Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.
抑制因子 NFI 和 NFY 参与了转基因小鼠血管性血友病因子启动子活性的组织特异性调节。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1423-9. doi: 10.1161/ATVBAHA.110.206680. Epub 2010 Apr 29.
4
Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions.内源性逆转录病毒插入所提供的人类特异性转录活性调控
J Virol. 2009 Jun;83(12):6098-105. doi: 10.1128/JVI.00123-09. Epub 2009 Apr 1.
5
Nuclear factor I X deficiency causes brain malformation and severe skeletal defects.核因子IX缺乏会导致脑畸形和严重的骨骼缺陷。
Mol Cell Biol. 2007 May;27(10):3855-3867. doi: 10.1128/MCB.02293-06.